価格表

在庫・価格 : 2024年05月03日 07時56分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Caspase-3, Rabbit-Poly
データシート※最新のデータシートでない場合があります
NB100-56112SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 ml ¥36,000
(未発注)
追加

在庫・価格 : 2024年05月03日 07時56分 現在

Anti-Caspase-3, Rabbit-Poly

  • 商品コード:NB100-56112SS
  • メーカー:NOV
  • 包装:0.025ml
  • 価格: ¥36,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Krajewska M et al. Early processing of Bid and caspase-6, -8, -10, -14 in the canine brain during cardiac arrest and resuscitation. Exp. Neurol. 2004 Oct;189(2):261-79
Krajewska M et al
2004/01/01
Species: Mouse, Canine, Rat, Applications: WB, IHC-P PubMed
2 Cheng TC et al. Potent anti-cancer effect of 3"-hydroxypterostilbene in human colon xenograft tumors. PLoS ONE 2014;9(11):e111814
Cheng TC et al
2014/01/01
Species: Human, Applications: WB PubMed
3 Samaga KK et al. Synthetic racemates of abyssinone I and II induces apoptosis through mitochondrial pathway in human cervix carcinoma cells. Bioorg. Chem. 2014 Oct;56:54-61
Samaga KK et al
2014/01/01
Species: Human, Applications: WB PubMed
4 Krajewski S et al. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin"s lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes. Blood 1997 May;89(10):3817-25
Krajewski S et al
1997/01/01
Applications: PubMed
5 Knoblach SM et al. Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome. J. Neurotrauma 2002 Oct;19(10):1155-70
Knoblach SM et al
2002/01/01
Applications: PubMed
6 Liu Q et al. FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood 2008 Jan;111(1):275-84
Liu Q et al
2008/01/01
Applications: PubMed
7 Svingen PA et al. Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia. Blood 2000 Dec;96(12):3922-31
Svingen PA et al
2000/01/01
Applications: PubMed
8 Zhao X et al. Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. Blood 2007 Oct;110(7):2569-77
Zhao X et al
2007/01/01
Applications: PubMed
9 Berger T et al. Interaction of DAP3 and FADD only after cellular disruption. Nat. Immunol. 2002 Jan;3(1):3-5
Berger T et al
2002/01/01
PubMed
  • No.: 1
  • 文献情報:
    Krajewska M et al. Early processing of Bid and caspase-6, -8, -10, -14 in the canine brain during cardiac arrest and resuscitation. Exp. Neurol. 2004 Oct;189(2):261-79
    Krajewska M et al
    2004/01/01
  • 備考:
    Species: Mouse, Canine, Rat, Applications: WB, IHC-P
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Cheng TC et al. Potent anti-cancer effect of 3"-hydroxypterostilbene in human colon xenograft tumors. PLoS ONE 2014;9(11):e111814
    Cheng TC et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Samaga KK et al. Synthetic racemates of abyssinone I and II induces apoptosis through mitochondrial pathway in human cervix carcinoma cells. Bioorg. Chem. 2014 Oct;56:54-61
    Samaga KK et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Krajewski S et al. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin"s lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes. Blood 1997 May;89(10):3817-25
    Krajewski S et al
    1997/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Knoblach SM et al. Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome. J. Neurotrauma 2002 Oct;19(10):1155-70
    Knoblach SM et al
    2002/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Liu Q et al. FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood 2008 Jan;111(1):275-84
    Liu Q et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Svingen PA et al. Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia. Blood 2000 Dec;96(12):3922-31
    Svingen PA et al
    2000/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Zhao X et al. Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. Blood 2007 Oct;110(7):2569-77
    Zhao X et al
    2007/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Berger T et al. Interaction of DAP3 and FADD only after cellular disruption. Nat. Immunol. 2002 Jan;3(1):3-5
    Berger T et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed